Targeting ERα degradation by L-Tetrahydropalmatine provides a novel strategy for breast cancer treatment

The incidence and mortality of breast cancer (BCa) are the highest among female cancers. There are approximate 70% BCa that are classified as estrogen receptor alpha (ERα) positive. Therefore, targeting ERα is the most significantly therapeutic schedule. However, patients with breast cancer develop...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Int J Biol Sci
Asıl Yazarlar: Xia, Xiaohong, He, Jinchan, Liu, Bin, Shao, Zhenlong, Xu, Qiong, Hu, Tumei, Yu, Cuifu, Liu, Xiaolin, Liao, Yuning, Liu, Ningning, Huang, Hongbiao
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Ivyspring International Publisher 2020
Konular:
Research Paper
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7294940/
https://ncbi.nlm.nih.gov/pubmed/32549765
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ijbs.44005
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller